AEGiS-ATDN: HCV/HIV Co-infection Treatments AIDS Treatment Data NetworkImportant note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu

HCV/HIV Co-infection Treatments

Information Bulletin #14 - March 2002

If you would like more information about HCV and HIV co-infection, and HCV treatment options, you can contact The Network at (800) 734-7104 or (212) 260-8868. A lot of new information regarding co-infection and the hepatitis C virus is becoming available. For example, a recent study showed that people who are HCV co-infected are more likely to experience liver toxicity from the drug nevirapine (Viramune) than HIV-positive people who are not infected with HCV. Protease inhibitors also seem to have more potential to cause liver damage in people who are co-infected. Several very important studies concerning HIV/HCV co-infection and treatment, as well as new information regarding lactic acidosis and mitochondrial toxicity, will be available very shortly as well.

Interested individuals who live in New York City, or receive HIV services of some type in New York are encouraged to contact us regarding our HIV/HCV education, treatment adherence, and counseling program. We will send you a full description of the program, and how it could help HIV-positive individuals to pay for both HIV and HCV treatments, as well as experimental treatment programs. The program also offers supportive counseling to co-infected individuals. Give us a call or e-mail to network@atdn.org.
020310
TR020307

Copyright © 2002 - AIDS Treatment Data Network. Reproduction of this article (other than one copy for personal reference) must be cleared through the AIDS Treatment Data Network. Email: .

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .